Canada Life’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$103K Sell
17,120
-550
-3% -$3.64K ﹤0.01% 1687
2025
Q4
$103K Sell
17,670
-44,252
-71% -$246K ﹤0.01% 1713
2025
Q3
$349K Hold
61,922
﹤0.01% 1644
2025
Q2
$243K Hold
61,922
﹤0.01% 1691
2025
Q1
$304K Buy
61,922
+44,252
+250% +$238K ﹤0.01% 1682
2024
Q4
$89K Sell
17,670
-10,010
-36% -$55.3K ﹤0.01% 1830
2024
Q3
$191K Sell
27,680
-35,683
-56% -$211K ﹤0.01% 1787
2024
Q2
$469K Buy
63,363
+35,683
+129% +$251K ﹤0.01% 1692
2024
Q1
$202K Hold
27,680
﹤0.01% 1829
2023
Q4
$170K Hold
27,680
﹤0.01% 1861
2023
Q3
$113K Buy
27,680
+18,512
+202% +$72.2K ﹤0.01% 1938
2023
Q2
$31K Hold
9,168
﹤0.01% 2069
2023
Q1
$44K Buy
+9,168
New +$30.9K ﹤0.01% 2082
2021
Q4
Sell
-4,582
Closed -$6K 2506
2021
Q3
$6K Hold
4,582
﹤0.01% 2519
2021
Q2
$35K Hold
4,582
﹤0.01% 2360
2021
Q1
$30K Hold
4,582
﹤0.01% 2441
2020
Q4
$30K Hold
4,582
﹤0.01% 2452
2020
Q3
$24K Hold
4,582
﹤0.01% 2395
2020
Q2
$32K Buy
+4,582
New +$31.9K ﹤0.01% 2378

Other funds holding ARDX

Canada Life's ARDX Position: Q1 2026 in Review

Canada Life reduced its Ardelyx (ARDX) stake by 3.1% in Q1 2026, selling an estimated $3.64K and leaving 17,120 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

Canada Life first reported a position in ARDX in Q2 2020 and has held it in 19 quarters since. The position peaked at $469K in Q2 2024. 239 funds tracked by Wall St. Rank hold ARDX as of Q1 2026.

  • Canada Life held 17,120 shares of Ardelyx worth $103K as of Q1 2026.
  • Canada Life sold 550 Ardelyx shares in Q1 2026, an estimated $3.64K.
  • Ardelyx made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1687 holding.
  • Canada Life first reported a position in Ardelyx in Q2 2020 and has held it in 19 quarters since.
  • Canada Life's Ardelyx position peaked at $469K in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Ardelyx as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.